Metformin selectively affects human glioblastoma tumor-initiating cell viability

References

• Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S, et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 2004; 64:7011 - 21; http://dx.doi.org/10.1158/0008-5472.CAN-04-1364; PMID: 15466194
   PubMed Web of Science ®Google Scholar
• Magee JA, Piskounova E, Morrison SJ. Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell 2012; 21:283 - 96; http://dx.doi.org/10.1016/j.ccr.2012.03.003; PMID: 22439924
   PubMed Web of Science ®Google Scholar
• Baccelli I, Trumpp A. The evolving concept of cancer and metastasis stem cells. J Cell Biol 2012; 198:281 - 93; http://dx.doi.org/10.1083/jcb.201202014; PMID: 22869594
   PubMed Web of Science ®Google Scholar
• Campos B, Wan F, Farhadi M, Ernst A, Zeppernick F, Tagscherer KE, et al. Differentiation therapy exerts antitumor effects on stem-like glioma cells. Clin Cancer Res 2010; 16:2715 - 28; http://dx.doi.org/10.1158/1078-0432.CCR-09-1800; PMID: 20442299
   PubMed Web of Science ®Google Scholar
• Hambardzumyan D, Squatrito M, Carbajal E, Holland EC. Glioma formation, cancer stem cells, and akt signaling. Stem Cell Rev 2008; 4:203 - 10; http://dx.doi.org/10.1007/s12015-008-9021-5; PMID: 18595010
   PubMed Web of Science ®Google Scholar
• Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003; 63:5821 - 8; PMID: 14522905
   PubMed Web of Science ®Google Scholar
• Eramo A, Ricci-Vitiani L, Zeuner A, Pallini R, Lotti F, Sette G, et al. Chemotherapy resistance of glioblastoma stem cells. Cell Death Differ 2006; 13:1238 - 41; http://dx.doi.org/10.1038/sj.cdd.4401872; PMID: 16456578
   PubMed Web of Science ®Google Scholar
• Favoni RE, Daga A, Malatesta P, Florio T. Preclinical studies identify novel targeted pharmacological strategies for treatment of human malignant pleural mesothelioma. Br J Pharmacol 2012; 166:532 - 53; http://dx.doi.org/10.1111/j.1476-5381.2012.01873.x; PMID: 22289125
   PubMed Web of Science ®Google Scholar
• Rich JN. Cancer stem cells in radiation resistance. Cancer Res 2007; 67:8980 - 4; http://dx.doi.org/10.1158/0008-5472.CAN-07-0895; PMID: 17908997
   PubMed Web of Science ®Google Scholar
• Liu G, Yuan X, Zeng Z, Tunici P, Ng H, Abdulkadir IR, et al. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 2006; 5:67; http://dx.doi.org/10.1186/1476-4598-5-67; PMID: 17140455
   PubMed Web of Science ®Google Scholar
• Cufi S, Corominas-Faja B, Vazquez-Martin A, Oliveras-Ferraros C, Dorca J, Bosch-Barrera J, et al. Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts. Oncotarget 2012; 3:395 - 8; PMID: 22565037
   PubMed Web of Science ®Google Scholar
• Ma Y, Liang D, Liu J, Axcrona K, Kvalheim G, Stokke T, et al. Prostate cancer cell lines under hypoxia exhibit greater stem-like properties. PLoS One 2011; 6:e29170; http://dx.doi.org/10.1371/journal.pone.0029170; PMID: 22216200
   PubMed Web of Science ®Google Scholar
• Martins-Neves SR, Lopes AO, do Carmo A, Paiva AA, Simões PC, Abrunhosa AJ, et al. Therapeutic implications of an enriched cancer stem-like cell population in a human osteosarcoma cell line. BMC Cancer 2012; 12:139; http://dx.doi.org/10.1186/1471-2407-12-139; PMID: 22475227
   PubMed Web of Science ®Google Scholar
• Meng E, Long B, Sullivan P, McClellan S, Finan MA, Reed E, et al. CD44+/CD24- ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival. Clin Exp Metastasis 2012; 29:939 - 48; http://dx.doi.org/10.1007/s10585-012-9482-4; PMID: 22610780
   PubMed Web of Science ®Google Scholar
• Hong Y, Sang M, Shang C, Xue YX, Liu YH. Quantitative analysis of topoisomerase II alpha and evaluation of its effects on cell proliferation and apoptosis in glioblastoma cancer stem cells. Neurosci Lett 2012; 518:138 - 43; http://dx.doi.org/10.1016/j.neulet.2012.04.071; PMID: 22569122
   PubMed Web of Science ®Google Scholar
• Chamberlain MC. Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas. Expert Rev Neurother 2010; 10:1537 - 44; http://dx.doi.org/10.1586/ern.10.32; PMID: 20925470
   PubMed Web of Science ®Google Scholar
• Evans JM, Donnelly LA, Emslie-Smith AM, Alessi DR, Morris AD. Metformin and reduced risk of cancer in diabetic patients. BMJ 2005; 330:1304 - 5; http://dx.doi.org/10.1136/bmj.38415.708634.F7; PMID: 15849206
   PubMed Web of Science ®Google Scholar
• Bowker SL, Majumdar SR, Veugelers P, Johnson JA. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin. Diabetes Care 2006; 29:254 - 8; http://dx.doi.org/10.2337/diacare.29.02.06.dc05-1558; PMID: 16443869
   PubMed Web of Science ®Google Scholar
• Jiralerspong S, Palla SL, Giordano SH, Meric-Bernstam F, Liedtke C, Barnett CM, et al. Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer. J Clin Oncol 2009; 27:3297 - 302; http://dx.doi.org/10.1200/JCO.2009.19.6410; PMID: 19487376
   PubMed Web of Science ®Google Scholar
• Algire C, Zakikhani M, Blouin MJ, Shuai JH, Pollak M. Metformin attenuates the stimulatory effect of a high-energy diet on in vivo LLC1 carcinoma growth. Endocr Relat Cancer 2008; 15:833 - 9; http://dx.doi.org/10.1677/ERC-08-0038; PMID: 18469156
   PubMed Web of Science ®Google Scholar
• Ben Sahra I, Laurent K, Loubat A, Giorgetti-Peraldi S, Colosetti P, Auberger P, et al. The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level. Oncogene 2008; 27:3576 - 86; http://dx.doi.org/10.1038/sj.onc.1211024; PMID: 18212742
   PubMed Web of Science ®Google Scholar
• Kisfalvi K, Eibl G, Sinnett-Smith J, Rozengurt E. Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth. Cancer Res 2009; 69:6539 - 45; http://dx.doi.org/10.1158/0008-5472.CAN-09-0418; PMID: 19679549
   PubMed Web of Science ®Google Scholar
• Zakikhani M, Dowling RJ, Sonenberg N, Pollak MN. The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase. Cancer Prev Res (Phila) 2008; 1:369 - 75; http://dx.doi.org/10.1158/1940-6207.CAPR-08-0081; PMID: 19138981
   PubMed Web of Science ®Google Scholar
• Chen G, Xu S, Renko K, Derwahl M. Metformin inhibits growth of thyroid carcinoma cells, suppresses self-renewal of derived cancer stem cells, and potentiates the effect of chemotherapeutic agents. J Clin Endocrinol Metab 2012; 97:E510 - 20; http://dx.doi.org/10.1210/jc.2011-1754; PMID: 22278418
   PubMed Web of Science ®Google Scholar
• Iliopoulos D, Hirsch HA, Struhl K. Metformin decreases the dose of chemotherapy for prolonging tumor remission in mouse xenografts involving multiple cancer cell types. Cancer Res 2011; 71:3196 - 201; http://dx.doi.org/10.1158/0008-5472.CAN-10-3471; PMID: 21415163
   PubMed Web of Science ®Google Scholar
• Vazquez-Martin A, Oliveras-Ferraros C, Del Barco S, Martin-Castillo B, Menendez JA. The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells. Breast Cancer Res Treat 2011; 126:355 - 64; http://dx.doi.org/10.1007/s10549-010-0924-x; PMID: 20458531
   PubMed Web of Science ®Google Scholar
• Hirsch HA, Iliopoulos D, Tsichlis PN, Struhl K. Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission. Cancer Res 2009; 69:7507 - 11; http://dx.doi.org/10.1158/0008-5472.CAN-09-2994; PMID: 19752085
   PubMed Web of Science ®Google Scholar
• Bolen S, Feldman L, Vassy J, Wilson L, Yeh HC, Marinopoulos S, et al. Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus. Ann Intern Med 2007; 147:386 - 99; PMID: 17638715
   PubMed Web of Science ®Google Scholar
• Kast RE, Karpel-Massler G, Halatsch ME. Can the therapeutic effects of temozolomide be potentiated by stimulating AMP-activated protein kinase with olanzepine and metformin?. Br J Pharmacol 2011; 164:1393 - 6; http://dx.doi.org/10.1111/j.1476-5381.2011.01320.x; PMID: 21410456
   PubMed Web of Science ®Google Scholar
• Griffero F, Daga A, Marubbi D, Capra MC, Melotti A, Pattarozzi A, et al. Different response of human glioma tumor-initiating cells to epidermal growth factor receptor kinase inhibitors. J Biol Chem 2009; 284:7138 - 48; http://dx.doi.org/10.1074/jbc.M807111200; PMID: 19147502
   PubMed Web of Science ®Google Scholar
• Shi WY, Xiao D, Wang L, Dong LH, Yan ZX, Shen ZX, et al. Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy. Cell Death Dis 2012; 3:e275; http://dx.doi.org/10.1038/cddis.2012.13; PMID: 22378068
   PubMed Web of Science ®Google Scholar
• Martin-Castillo B, Vazquez-Martin A, Oliveras-Ferraros C, Menendez JA. Metformin and cancer: doses, mechanisms and the dandelion and hormetic phenomena. Cell Cycle 2010; 9:1057 - 64; http://dx.doi.org/10.4161/cc.9.6.10994; PMID: 20305377
   PubMed Web of Science ®Google Scholar
• Favoni RE, Pattarozzi A, Lo Casto M, Barbieri F, Gatti M, Paleari L, et al. Gefitinib targets EGFR dimerization and ERK1/2 phosphorylation to inhibit pleural mesothelioma cell proliferation. Curr Cancer Drug Targets 2010; 10:176 - 91; http://dx.doi.org/10.2174/156800910791054130; PMID: 20088784
   PubMed Web of Science ®Google Scholar
• Florio T, Barbieri F. The status of the art of human malignant glioma management: the promising role of targeting tumor-initiating cells. Drug Discov Today 2012; 17:1103 - 10; http://dx.doi.org/10.1016/j.drudis.2012.06.001; PMID: 22704957
   PubMed Web of Science ®Google Scholar
• He J, Shan Z, Li L, Liu F, Liu Z, Song M, et al. Expression of glioma stem cell marker CD133 and O6-methylguanine-DNA methyltransferase is associated with resistance to radiotherapy in gliomas. Oncol Rep 2011; 26:1305 - 13; PMID: 21769436
   PubMed Web of Science ®Google Scholar
• Metellus P, Nanni-Metellus I, Delfino C, Colin C, Tchogandjian A, Coulibaly B, et al. Prognostic impact of CD133 mRNA expression in 48 glioblastoma patients treated with concomitant radiochemotherapy: a prospective patient cohort at a single institution. Ann Surg Oncol 2011; 18:2937 - 45; http://dx.doi.org/10.1245/s10434-011-1703-6; PMID: 21479688
   PubMed Web of Science ®Google Scholar
• Soeda A, Inagaki A, Oka N, Ikegame Y, Aoki H, Yoshimura S, et al. Epidermal growth factor plays a crucial role in mitogenic regulation of human brain tumor stem cells. J Biol Chem 2008; 283:10958 - 66; http://dx.doi.org/10.1074/jbc.M704205200; PMID: 18292095
   PubMed Web of Science ®Google Scholar
• Navé BT, Ouwens M, Withers DJ, Alessi DR, Shepherd PR. Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. Biochem J 1999; 344:427 - 31; http://dx.doi.org/10.1042/0264-6021:3440427; PMID: 10567225
   PubMed Web of Science ®Google Scholar
• Qu Z, Zhang Y, Liao M, Chen Y, Zhao J, Pan Y. In vitro and in vivo antitumoral action of metformin on hepatocellular carcinoma. Hepatol Res 2012; 42:922 - 33; http://dx.doi.org/10.1111/j.1872-034X.2012.01007.x; PMID: 22524458
   PubMed Web of Science ®Google Scholar
• Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, Weinberg RA, et al. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 2009; 138:645 - 59; http://dx.doi.org/10.1016/j.cell.2009.06.034; PMID: 19682730
   PubMed Web of Science ®Google Scholar
• Sachlos E, Risueño RM, Laronde S, Shapovalova Z, Lee JH, Russell J, et al. Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells. Cell 2012; 149:1284 - 97; http://dx.doi.org/10.1016/j.cell.2012.03.049; PMID: 22632761
   PubMed Web of Science ®Google Scholar
• Garrett CR, Hassabo HM, Bhadkamkar NA, Wen S, Baladandayuthapani V, Kee BK, et al. Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer. Br J Cancer 2012; 106:1374 - 8; http://dx.doi.org/10.1038/bjc.2012.71; PMID: 22421948
   PubMed Web of Science ®Google Scholar
• Colao A, Vitale P, Faggiano A. Diabetes and cancer. Front Endocrinol (Lausanne) 2011; 2:22; http://dx.doi.org/10.3389/fendo.2011.00022; PMID: 22649367
   PubMedGoogle Scholar
• Sikka A, Kaur M, Agarwal C, Deep G, Agarwal R. Metformin suppresses growth of human head and neck squamous cell carcinoma via global inhibition of protein translation. Cell Cycle 2012; 11:1374 - 82; http://dx.doi.org/10.4161/cc.19798; PMID: 22421144
   PubMed Web of Science ®Google Scholar
• Rattan R, Ali Fehmi R, Munkarah A. Metformin: an emerging new therapeutic option for targeting cancer stem cells and metastasis. J Oncol 2012; 2012:928127; http://dx.doi.org/10.1155/2012/928127; PMID: 22701483
   PubMedGoogle Scholar
• Del Barco S, Vazquez-Martin A, Cufí S, Oliveras-Ferraros C, Bosch-Barrera J, Joven J, et al. Metformin: multi-faceted protection against cancer. Oncotarget 2011; 2:896 - 917; PMID: 22203527
   PubMed Web of Science ®Google Scholar
• Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006; 9:391 - 403; http://dx.doi.org/10.1016/j.ccr.2006.03.030; PMID: 16697959
   PubMed Web of Science ®Google Scholar
• Vakana E, Platanias LC. AMPK in BCR-ABL expressing leukemias. Regulatory effects and therapeutic implications. Oncotarget 2011; 2:1322 - 8; PMID: 22249159
   PubMed Web of Science ®Google Scholar
• Memmott RM, Mercado JR, Maier CR, Kawabata S, Fox SD, Dennis PA. Metformin prevents tobacco carcinogen--induced lung tumorigenesis. Cancer Prev Res (Phila) 2010; 3:1066 - 76; http://dx.doi.org/10.1158/1940-6207.CAPR-10-0055; PMID: 20810672
   PubMed Web of Science ®Google Scholar
• Menendez JA, Vazquez-Martin A. Rejuvenating regeneration: Metformin activates endogenous adult stem cells. Cell Cycle 2012; 11:3521 - 2; http://dx.doi.org/10.4161/cc.21878; PMID: 22935702
   PubMed Web of Science ®Google Scholar
• Wang J, Gallagher D, DeVito LM, Cancino GI, Tsui D, He L, et al. Metformin activates an atypical PKC-CBP pathway to promote neurogenesis and enhance spatial memory formation. Cell Stem Cell 2012; 11:23 - 35; http://dx.doi.org/10.1016/j.stem.2012.03.016; PMID: 22770240
   PubMed Web of Science ®Google Scholar
• Menendez JA, Oliveras-Ferraros C, Cufí S, Corominas-Faja B, Joven J, Martin-Castillo B, et al. Metformin is synthetically lethal with glucose withdrawal in cancer cells. Cell Cycle 2012; 11:2782 - 92; http://dx.doi.org/10.4161/cc.20948; PMID: 22809961
   PubMed Web of Science ®Google Scholar
• Joo KM, Kim SY, Jin X, Song SY, Kong DS, Lee JI, et al. Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas. Lab Invest 2008; 88:808 - 15; http://dx.doi.org/10.1038/labinvest.2008.57; PMID: 18560366
   PubMed Web of Science ®Google Scholar
• Kemper K, Versloot M, Cameron K, Colak S, de Sousa e Melo F, de Jong JH, et al. Mutations in the Ras-Raf Axis underlie the prognostic value of CD133 in colorectal cancer. Clin Cancer Res 2012; 18:3132 - 41; http://dx.doi.org/10.1158/1078-0432.CCR-11-3066; PMID: 22496204
   PubMed Web of Science ®Google Scholar
• Würth R, Barbieri F, Bajetto A, Pattarozzi A, Gatti M, Porcile C, et al. Expression of CXCR7 chemokine receptor in human meningioma cells and in intratumoral microvasculature. J Neuroimmunol 2011; 234:115 - 23; http://dx.doi.org/10.1016/j.jneuroim.2011.01.006; PMID: 21316111
   PubMed Web of Science ®Google Scholar
• Barbieri F, Bajetto A, Stumm R, Pattarozzi A, Porcile C, Zona G, et al. Overexpression of stromal cell-derived factor 1 and its receptor CXCR4 induces autocrine/paracrine cell proliferation in human pituitary adenomas. Clin Cancer Res 2008; 14:5022 - 32; http://dx.doi.org/10.1158/1078-0432.CCR-07-4717; PMID: 18698020
   PubMed Web of Science ®Google Scholar
• Pattarozzi A, Gatti M, Barbieri F, Würth R, Porcile C, Lunardi G, et al. 17beta-estradiol promotes breast cancer cell proliferation-inducing stromal cell-derived factor-1-mediated epidermal growth factor receptor transactivation: reversal by gefitinib pretreatment. Mol Pharmacol 2008; 73:191 - 202; http://dx.doi.org/10.1124/mol.107.039974; PMID: 17959712
   PubMed Web of Science ®Google Scholar
• Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8:315 - 7; http://dx.doi.org/10.1080/14653240600855905; PMID: 16923606
   PubMed Web of Science ®Google Scholar
• Givan AL, Fisher JL, Waugh M, Ernstoff MS, Wallace PK. A flow cytometric method to estimate the precursor frequencies of cells proliferating in response to specific antigens. J Immunol Methods 1999; 230:99 - 112; http://dx.doi.org/10.1016/S0022-1759(99)00136-2; PMID: 10594357
   PubMed Web of Science ®Google Scholar
• Hofmann M, Wollert KC, Meyer GP, Menke A, Arseniev L, Hertenstein B, et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 2005; 111:2198 - 202; http://dx.doi.org/10.1161/01.CIR.0000163546.27639.AA; PMID: 15851598
   PubMed Web of Science ®Google Scholar
• Barbieri F, Würth R, Favoni RE, Pattarozzi A, Gatti M, Ratto A, et al. Receptor tyrosine kinase inhibitors and cytotoxic drugs affect pleural mesothelioma cell proliferation: insight into EGFR and ERK1/2 as antitumor targets. Biochem Pharmacol 2011; 82:1467 - 77; http://dx.doi.org/10.1016/j.bcp.2011.07.073; PMID: 21787763
   PubMed Web of Science ®Google Scholar